How to Check Star Imaging & Path Lab IPO Allotment Status? Check Status on Registrar & BSE

Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests, incorporated in 2004. The company specializes in imaging services such as X-rays, ultrasounds, CT scans, MRIs, and laboratory tests including blood tests, urine tests, and other specialized diagnostics, with 209 full-time employees as of September 30, 2024, and maintains a strong presence in multiple regions offering services to both individuals and healthcare institutions primarily in and around Delhi region.

The Star Imaging IPO came with a total issue size of ₹69.47 crore, comprising a fresh issue of 0.39 crore shares aggregating to ₹55.66 crore and offer for sale of 0.10 crore shares aggregating to ₹13.80 crore. The IPO opened on August 8, 2025, and closed on August 12, 2025. The allotment for the Star Imaging IPO is expected to be finalized on Wednesday, August 13, 2025. The Star Imaging IPO share price band was set at ₹135 to ₹142 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Star Imaging & Path Lab IPO Allotment Status on Registrar Site

• Visit the Kfin Technologies Ltd. website 
• Select "Star Imaging & Path Lab" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Star Imaging & Path Lab IPO Allotment Status on BSE

• Navigate to the BSE IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "Star Imaging & Path Lab" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Star Imaging & Path Lab IPO Subscription Status

Star Imaging IPO received moderate investor interest, being subscribed 5.67 times overall. The subscription showed reasonable confidence across categories in the Star Imaging IPO stock price potential. Here is a category-wise breakdown of the subscription as of 5:04:32 PM on August 12, 2025:

• Non-Institutional Investors (NII): 4.38 times.
• QIB Category: 12.85 times.
• Employee: 0.31

Star Imaging & Path Lab Share Price and Investment Details

The Star Imaging IPO stock price band was set at ₹135 to ₹142 per share with a minimum lot size of 1,000 shares. The minimum investment required for individual investors was ₹2,84,000 for 2 lots (2,000 shares). The issue included up to 13,04,000 shares allocated to anchor investors raising ₹18.52 crore. Given the moderate subscription response of 5.67 times overall, with QIB category showing strong response at 12.85 times and NII demonstrating moderate response at 4.38 times, the Star Imaging IPO share price is expected to list with moderate premium.

Utilisation of IPO Proceeds

The IPO is a complete offer for sale. Hence, the company will not receive any proceeds. The objective of the issue is to:

• To Meet Working Capital Requirement: ₹25.00 crore.
• Repayment/prepayment of certain borrowings availed of by the Company: ₹12.00 crore.
• Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities: ₹5.14 crore.
• General corporate purposes: Remaining amount.

Business Overview

Star Imaging and Path Lab Limited is a healthcare company operating diagnostic testing network providing comprehensive diagnostic services including radiology services such as digital X-ray, mammography, CT scans, 4D & 5D ultrasound services, and pathology services including haematology, microbiology, PCR, and histopathology. The company operates with advanced technology and experienced medical professionals across B2C, B2B, and B2G business models, offering accurate and timely reports to patients and healthcare providers for effective diagnosis and treatment. With specialized expertise in accurate diagnosis and proper sample collection and processing procedures, the company maintains a strong presence in multiple regions serving both individuals and healthcare institutions while focusing on routine testing and special testing diagnostics to help healthcare providers deliver quality medical care.